Copper and zinc isotopic excursions in the human brain affected by Alzheimer’s disease by Moynier, Frédéric et al.
Received: 18 June 2020 Revised: 30 August 2020 Accepted: 2 September 2020 Published online: 13October 2020
DOI: 10.1002/dad2.12112
S HORT R E PORT
Copper and zinc isotopic excursions in the human brain
affected by Alzheimer’s disease
FrédéricMoynier1 Marie Le Borgne2 Esther Lahoud1 BrandonMahan3
FrancoisMouton-Ligier4 Jacques Hugon4 Claire Paquet4
1 Institut de Physique du Globe de Paris,
Université de Paris, CNRS, Paris, France
2 Unité 1148, Institut National de la Santé et
de la RechercheMédicale (INSERM), Hôpital
Xavier Bichat GHUNord APHP, Département
Hospitalo-Universitaire DHU FIRE, Université
de Paris, Paris, France
3 Earth and Environmental Sciences, James
Cook University, Townsville, Queensland,
Australia
4 Centre de Neurologie Cognitive, Hopital
Lariboisière Fernand-Widal GHUNord APHP
Université de Paris, and Inserm, Paris, France
Correspondence
FrédéricMoynier, Institut dePhysiquedu




Introduction:Alzheimer’s disease (AD) is neuropathologically marked by amyloid beta
(Aβ) plaques and neurofibrillary tangles. Little is known about isotopic compositions of
human AD brains. Here we study this in comparison with control subjects for copper
and zinc.
Methods: We use mass-spectrometry methods, developed to study extraterrestrial
materials, to compare the copper and zinc isotopic composition of 10 AD and 10 con-
trol brains.
Results: Copper and zinc natural isotopic compositions of AD brains are statistically
different compared to controls, and correlate with Braak stages.
Discussion: The distribution of natural copper and zinc isotopes in AD is not affected
by the diet, but is a consequence of Aβ plaques and tau fibril accumulation. This is well
predicted by the changes of the chemical bonding environment caused by the develop-
ment of Aβ lesions and accumulation of tau proteins. Future work will involve testing
whether these changes affect brain functions and are propagated to body fluids.
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1 INTRODUCTION
Metals are concentrated in the amyloid beta (Aβ) plaques and tau fil-
aments of the neocortex in patients with Alzheimer’s disease (AD),1–3
and changes inmetal homeostasis associatedwithADhavebeen tested
as a diagnostic tool. Furthermore, it has also been shown that zinc and
copper can induce the precipitation of Aβ and possibly tau, with zinc
being especially critical with respect to aggregation.3–5 However, stud-
ies focusing on elemental abundance in the serum of AD patients are
inconsistent,6 as theymay be affected by factors unrelated to AD, such
as intestinal absorption.7
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Technical advances in geo-cosmochemistry now allow for ultra-
precise measurements of metal natural isotopic compositions, for
example, to study the origin of the Moon.8 More recently these
techniques have shown that the copper and zinc isotopic composition
of blood is distinct from that in the brain, with amagnitude comparable
to that observed in cosmic/planetary processes.9–11 These natural
isotopic variations are controlled by the difference of speciation of
the elements between bodily reservoirs, and notably are not affected
by diet.9 Equilibrium isotopic fractionation is due to the difference
of energy between systems and, in general, heavier isotopes become
more concentrated where the element forms the strongest bonds.
Alzheimer’s Dement. 2020;12:e12112. wileyonlinelibrary.com/journal/dad2 1 of 5
https://doi.org/10.1002/dad2.12112
2 of 5 MOYNIER ET AL.
Because accumulation of Aβ plaques and tau proteins induces changes
of bonding environments in the AD brain, a change in brain isotopic
composition should be induced, and by mass balance this change
should be mirrored in body fluids (an approach similar to what has
already been successfully in cancer research12). For example, zinc inAβ
plaques binds to three histidine residues in the N-terminal hydrophilic
regionAβ16 of theAβ peptide,13,14 whereas in normal brain it ismostly
bound to cysteine within metallothionein.15 Zinc bound to histidine is
isotopically heavier than cysteine by ≈0.6‰ at 298K because it forms
tighter bonds,9 and therefore we would expect the AD brains to be
heavier than controls due to a net change in the bonding environment.
This difference of bound energy is enhanced for elements that would
be present in different redox states between different phases. This
is not the case for zinc (or Zn, always +2), but it is for copper (or
Cu, +1 or +2), and therefore copper should present larger isotopic
variations.
In summary, the formation of Aβ plaques induces a change in the
bonding environments of metals in AD brains and this change should
manifest asdisturbances inmetal isotope compositions,where thegen-
eral direction (positiveor negative) andmagnitudeof these changes are
theoretically constrained. Bymass balance, the inverse of the changeof
isotopic composition in the brain should be transferred to other organs
and body fluids. Although the full scope of these theoretical sugges-
tions requires further scrutiny, recent zinc isotopic work on Aβ aggre-
gation experiments agree with theoretical estimates, lending evidence
to the validity of this framework.16
The isotopic effects ofAβplaques accumulation havebeen tested on
APPswe/PSEN1dE9and controlmice for copper and zinc isotopes.17,18
The brains of APPswe/PSEN1dE9 mice that developed Aβ plaques
were enriched in the light isotope of copper,18 and the heavy iso-
topes of zinc.17 These isotopic differences are consistent with the
changes of copper and zinc speciation associatedwith the formation of
Aβ plaques.17,18 Furthermore, the copper isotopic composition of the
brains and serumwere correlated, implying copper transport between
these two reservoirs, in particular a transfer of Cu(I) from the brain to
the serum, illustrating the potential to be used as detection tools for
the formation of Aβ fibrils in the brain. However, it has been shown that
serum isotopic compositions for human and mouse models can be dif-
ferent, and the human serum values reported herein are heavier than
what is reported for mice by ≈0.5‰ [eg,12, 19-21]. It is therefore fun-
damental to validate these discoveries on human samples.
Herewe testwhether isotopic variationsof humanbrains areassoci-
ated with the development of the AD on 20 well-characterized human
brain (frontal cortex) samples: 10 with clear AD diagnostics (Braak
stages V-VI) and 10 controls (Braak stages 0-II).
2 METHODS
2.1 Brains
Frozen prefrontal brain tissues from patients with AD Braak stages
V-VI (see Table S1) were obtained from the Center of Cognitive
RESEARCH INCONTEXT
1. Systematic review: The authors reviewed the literature
using traditional sources (eg, ISI web of Science, PubMed)
and meeting abstracts and presentations. All relevant
publications are cited.
2. Interpretation: Our findings of a difference in zinc and
coppernatural isotopic compositionbetweenAlzheimer’s
disease (AD) and control brains validate the hypothesis
that the change of metal speciation due to the accumula-
tion of amyloid beta (Aβ) and tau proteins affect themetal
homeostasis of the brain.
3. FutureDirections: This article presents the first observa-
tion of natural isotopic fractionation induced by the AD
in brains. Future work will be related to providing a theo-
retical and experimental framework for the fractionation
induced by tau accumulation, and investigate whether
these effects are propagated to body fluids and whether
they affect brain function.
Neurology, Lariboisière Hospital with approval by the Ethical Com-
mittee of Paris Diderot University Hospitals (CEERB Bichat University
Hospital, Paris, France). All AD patients had a history of progressive
dementia, satisfying National Institute of Neurological and Commu-
nicative Disorders and Stroke–Alzheimer’s Disease and Related Disor-
ders criteria for probable AD,22 and satisfying neuropathological cri-
teria for AD,23 whereas all controls satisfied no neuropathological AD
criteria.
2.2 Chemical purification and mass-spectrometry
Copper and zinc isotopic measurements were performed at the Insti-
tut de Physique du Globe de Paris, France, following the protocol
described before.11,17,18
It is not feasible to obtain precise absolute isotopic ratios, and there-




























The sample-to-sample comparisons (eg, AD vs control) are relativis-
tic anddiscussed in termsof being heavier (or lighter) thanone another.
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F IGURE 1 Effect of Alzheimer’s disease (AD) on copper (A) and
zinc (B) isotopic composition of the brains. Unpaired t tests show a
significant effect of AD for copper isotopes (P= .0002) and to a lesser
extent on zinc (P= .025). AD brains aremore enriched in the lighter
isotopes of copper than controls
3 RESULTS
The isotopic data are reported in Table S1. The copper isotopic com-
position of 19 samples (9 AD) and the zinc isotopic composition of 18
samples (9 AD) were possible to measure. The copper isotopic compo-
sition of human brains (average δ65Cu = +0.60 ± 0.13, for controls)
falls within what was measured for mouse brain (+0.56 ± 0.28 for
controls,18). Human brain is therefore enriched in the heavy isotope
of copper compared to serum (δ65Cu = 0.10 ± 0.22,12), as observed
in mice.18 The human brain is enriched in the light isotopes of zinc
(δ66 Zn = −0.6 ± 0.20 for the controls) as for Gottingen minipigs
(−0.80± 0.05) andmice (δ66 Zn=−0.20± 0.27,17).
δ65Cu is not statistically dependent (r2= 0.04 and P= .1) on age for
both controls (22 to 97 years) andAD (66 to 95 years) (Figure S1a). The
same is true for δ66 Zn (Figure S1b), albeit the controls show a weak
(but statistically insignificant, r2= 0.37, P = .08) positive correlation
with the age.
Neither the copper nor the zinc isotopic composition is statistically
dependent on sex for both controls and AD (Figure S2), and in the fol-
lowing bothmale and female are treated together.
AD brains are isotopically lighter for copper (δ65Cu = 0.35 ± 0.13)
than control patients (δ65Cu = 0.60 ± 0.14) (Figure 1A), which is
F IGURE 2 Isotopic composition of copper and zinc as a function
of the Braak stage. Both δ65Cu and δ66 Zn vary systematically with the
Braak stage, with P values of 0.0028 and 0.0142, respectively
statistically significant (P = .0002). The zinc isotopic composition of
AD and control brains are also statistically distinct (Figure 1B), but
this difference is weaker than in the case of copper (P = .024), the
difference between control and AD brains.
In summary, the brains ofADpatients havedifferent copper and zinc
stable isotopic composition compared to controls (see Figure 1), with
a difference of −0.18 for δ65Cu and 0.20 for δ66 Zn. There is a statis-
tical interaction between δ65Cu and δ66 Zn (two-way analysis of the
variance, P = .0005), and this is also seen in the δ65Cu-δ66 Zn corre-
lation (Figure S3), suggesting that zinc and copper isotope variations
have similar origins.
4 DISCUSSION
Our results reveal that the copper and zinc isotopic composition of AD
brains is different from controls in a statistically meaningful way.
The copper and zinc isotopic variations are in the same direction as
observed previously in 12month-old APPswe/PSEN1dE9 mice, with
δ65Cu decreasing and δ66 Zn increasing in the brain of AD mice com-
pared to controls,17,18 but this effect is stronger in humans (Figure 1).
Both δ65Cu and δ66 Zn vary with Braak stage in a statistically
meaningful correlation, reflecting an input from tangles (Figure 2).
This shows that the changes in the isotopic composition correlate
with the evolution of AD, and is a strong indication that an extra cause
of the isotopic changes of the brains could be associated with the
accumulations of neurofibrillary tangle in neurons. This necessitates
the deconvolution of potential mechanistic drivers for the observed
isotopic compositions, in particular, questioning the role of tangles and
Aβ peptide aggregation. Furthermore, this result questions the impact
of such accumulations on brain functions, which by default asks if their
associated isotopic changes are of medical or diagnostic utility.
The AD-associated isotopic change in the brain must be related
to the disruption of copper and zinc homeostasis. The heavy isotope
enrichment of zinc in AD is consistent with the change in speciation
in AD brains due to the development of Aβ plaques. Grossly assum-
ing that these isotopic differences between amino acids represent the
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isotopic difference between Aβ and normal brain (zinc bound to histi-
dine is isotopically heavier than cysteine by ≈0.6‰ at 298K9), the AD
brain should be enriched by ≈50% in Zn, in line with typical estimates
(eg, factor 2 in Zn2). The accumulation of isotopically heavyAβ is there-
fore a well-reasoned explanation for the zinc composition of AD brain.
Copper has multiple redox states (Cu+ and Cu2+), and isotopic frac-
tionation is enhanced by redox change, likely explaining the larger and
statistically more significant isotopic shift observed for copper relative
to zinc. Copper is primarily bound as Cu2+ to cysteine in normal brain,
whereas in Aβ plaques it can be Cu+.24,25 Reduced phases, such as Cu+
here, are isotopically lighter than oxidized phases (Cu2+). Therefore,
even in the absence of theoretical calculations, the enrichment of Aβ
in Cu+ may qualitatively explain the low δ65Cu of AD brains.
An additional effect is the binding of copper and zinc to tau
tangles.26 Cu+ can bind strongly to histidine residues of the tau
proteins,26 which would be enriched in the light isotope compared
to normal brains (Cu2+ bound to cysteine) and would enhance the
effect seen with Aβ aggregation. On the other hand, Zn2+ can bind to
histidine in tau proteins,27 whichwould therefore be isotopically heav-
ier than normal brain. The effect of tau proteins is further supported
by the correlation between copper and zinc isotopic compositions
and the Braak stages (Figure 2), a metric that is strongly based on
neurofibrillary tangles. For copper especially, the effect of isotopically
light tau proteins may explain the larger copper isotopic difference in
humans than inmicemodels that do not develop tau accumulation.
In summary, copper and zinc natural isotopic compositions of brain
tissue from AD patients are modified compared to controls and corre-
lates with the Braak stages. The isotopic excursions observed within
the brain are similar in magnitude to what is observed in Moon sam-
ples. Given that much knowledge has been added to the cosmochem-
istry cannon by exploring isotopic variation,8 this underscores great
promise for the use of isotopes in medical research. These changes are
not dependent on the sex, diet, or the age of the patients. These iso-
topic fractionations are well predicted by the changes of speciation of
copper and zinc due to the development of Aβ lesions and the accumu-
lation of tau proteins. The next step is to test whether the changes in
isotopic composition affect brain functions andwhether these changes
are propagated to body fluids.
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